Literature DB >> 19349431

Self-surveillance by adolescents and young adults transitioning to self-management of a chronic genetic disorder.

Ellen Giarelli1, Barbara A Bernhardt, Reed E Pyeritz.   

Abstract

Adolescents and young adults with Marfan syndrome (MFS) use information from self-surveillance to manage their disorder. Thirty-seven male and female adolescents with MFS aged 14 to 21 years were interviewed. They identified 58 distinct self-surveillance behaviors that fell into four categories and multiple subcategories (SCs): tracking phenotype (SCs: physical appearance, physical fitness, medical problems, and other observations); tracking medical care (SCs: medical evaluations and treatments, and pharmacotherapy); tracking behavior (SCs: personal choices and social relations); and tracking emotions (SCs: positive emotional impact and negative emotional impact). The frequency and range of self-monitoring increased with the age of the child. On average, a child of 14 self-monitored from 1 to 3 times per day, whereas a person aged 21 might self-monitor many more times per day. The patient-parent-physician relationship is the context for teaching adolescents and young adults self-surveillance skills. Self-surveillance by patients is first-line symptom assessment and an adjunct to medical monitoring.

Entities:  

Mesh:

Year:  2009        PMID: 19349431     DOI: 10.1177/1090198109331670

Source DB:  PubMed          Journal:  Health Educ Behav        ISSN: 1090-1981


  2 in total

Review 1.  A Review of Psychosocial Factors of Marfan Syndrome: Adolescents, Adults, Families, and Providers.

Authors:  Cory Nielsen; Ileana Ratiu; Mitra Esfandiarei; Angela Chen; Elif Seda Selamet Tierney
Journal:  J Pediatr Genet       Date:  2019-07-25

Review 2.  Marfan syndrome.

Authors:  Dianna M Milewicz; Alan C Braverman; Julie De Backer; Shaine A Morris; Catherine Boileau; Irene H Maumenee; Guillaume Jondeau; Arturo Evangelista; Reed E Pyeritz
Journal:  Nat Rev Dis Primers       Date:  2021-09-02       Impact factor: 65.038

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.